Cardiovascular diseases are the leading cause of death worldwide. The Vascular Epigenetics research group aims to understand how the metabolic environment shapes vascular disease susceptibility. To do so, our research integrates mechanistic studies, animal models and analyses of human patient material to develop a holistic view of molecular mechanisms underlying disease risk. The long-term aim is to develop clinical strategies to reduce the risk of diseases driven by vascular dysfunction.

We are always on the look for new colleagues interested in vascular dysfunction, metabolism and epigenetics. If you are interested in working with our group, please get in touch.